A subtype of the diffuse large B cell lymphoma (DLBCL) is activated B cell-like DLBCL, where it has been reported that IgM-positivity of tumor correlates with a poor prognosis and a shorter overall survival for patients (10–12). Here, CD40LG is linked to diffuse large B-cell lymphoma.